Tulane Researchers Develop Inhaled Vaccine Against Bacterial Pneumonia
September 11, 2021
September 11, 2021
NEW ORLEANS, Louisiana, Sept. 11 (TNSJou) -- Tulane University issued the following news release:
Researchers at Tulane University School of Medicine have developed an inhaled vaccine against Klebsiella pneumoniae, a bacterium that can cause pneumonia in hospital settings. The vaccine was able to protect mice against several strains of the bacteria, according to a new study published in Science Immunology.
There are currently no FDA-licensed vaccines for the prevention . . .
Researchers at Tulane University School of Medicine have developed an inhaled vaccine against Klebsiella pneumoniae, a bacterium that can cause pneumonia in hospital settings. The vaccine was able to protect mice against several strains of the bacteria, according to a new study published in Science Immunology.
There are currently no FDA-licensed vaccines for the prevention . . .